Qiancheng Shen

CEO

Nutshell Therapeutics

Short Biography

Dr. Qiancheng Shen is the Co-Founder and CEO of Nutshell Therapeutics. She obtained her Ph.D degree from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, with interdisciplinary research backgrounds in biology, computational chemistry, and clinical bioinformatics.

Presentation Topic: AI-powered allosteric drug discovery

Nutshell Therapeutics is a dedicated biotech company specializing in allosteric drug discovery for those historically undruggable targets. We have developed a proprietary AI + physics based platform named ALLOSTARTM, which is designed to identify and profile the hidden pockets on proteins, as well as discover or optimize allosteric ligands. Furthermore, leveraging our platform, we have established potential BIC/FIC allosteric drug pipelines. These pipelines comprise allosteric activators and inhibitors, with a predominant focus on oncology and metabolic diseases.